FindTrial
Sign In

clinical and experimental study of direct aplication of growth factors and ofloxacin ear drops on tympanic membrane perforation

clinical and experimental study of direct aplication of growth factors and ofloxacin ear drops on tympanic membrane perforation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCQ-15006897
Enrollment
Unknown
Registered
2015-08-08
Start date
2011-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

traumatic tympanic membrane perforation

Interventions

EGF group:topical aplication of EGF
FGF group:topical aplication of EGF
FLOX group:topical aplication of FLOX

Sponsors

The Affiliated YiWu Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 75 Years

Inclusion criteria

Inclusion criteria: Traumatic tympanic membrane perforation with the age from 6-75 years; the perforation size at least one-fourth of the pars tensa

Exclusion criteria

Exclusion criteria: Patients were excluded if physical examinations revelled any of the following conditions: granulation tissue or purulent otorrhoea within the ear, severe vertigo, profound hearing loss or ossicular disruption.

Design outcomes

Primary

MeasureTime frame
the closure rate;closure time;—

Countries

China

Contacts

Public Contactzhengcai Lou
louzhengcai@163.com+86 13738996868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026